Navigation Links
Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology

Elucidation of CF502 mechanism of action and the ability to examine this activity in human cells improve the chances that this drug can offer effective treatment for patients."

CF502, which is being developed by Can-Fite, became part of the development pipeline after Can-Fite had signed a prestigious agreement with the NIH, the leading research institute in the US. Under this agreement, titled CRADA, Can-Fite now cooperates with the laboratory of Prof. Jacobson, a worldwide leading scientist in the field of A3 adenosine receptor agonists and antagonists. Can-Fite is currently in negotiations with the NIH for the licensing of the CF502 molecule.

In addition to CF502, Can-Fite's development pipeline also includes two other drugs, CF101 which is being evaluated for rheumatoid arthritis, dry eye syndrome and psoriasis in phase I clinical trials, and CF102 which is intended for the treatment of liver cancer and hepatitis B. The Company's first commercial agreement was signed with the Japanese Seikagaku Corporation during development of CF101, under the terms of which Can-Fite has already received about USD 5 million.

CAN-FITE BIOPHARMA LTD is a public company traded on the Tel Aviv Stock Exchange. The Company, which commenced business activity in 2000, was founded by researcher Prof. Pnina Fishman and patent attorney Dr. Ilan Cohn. The Company focuses on the development of molecule-based drugs that inhibit the development of cancer or inflammatory cells. The market for the company's drugs is estimated at billions of dollars.

Contact

Can-Fite BioPharma
Pnina Fishman, Ph.D., +972-3-9241114
Chief Executive Officer
Fax: +972-3-9249378
pnina@canfite.co.il
http://www.canfite.com/


'"/>




Page: 1 2

Related medicine technology :

1. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
2. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
3. Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule, Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for Clinical Development in Chronic Hepatitis C Virus Infection
4. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
5. CuraGen Presents Update on Clinical Development Program for Belinostat
6. New Critical Path Report Highlights Research Needed to Foster Generic Drug Development
7. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
8. ImClone Systems Showcases Extensive Research and Development Program at the AACR Annual Meeting
9. Alnylam Announces Advancement of a New RNAi Therapeutic Development Program for the Treatment of Liver Cancer
10. Biomira Selects PX-866 as Clinical Development Candidate and Presents Promising Preclinical Data at AACR
11. Newly Released Canadian Data Links Vaccines with Pervasive Developmental Disorder

Post Your Comments:
(Date:11/7/2009)...7 Most patients with hereditary an... an oncoming HAE attack giving the patients suffic...orbidity associated with that attack, according to...can College of Allergy, Asthma & Immunology (A...s such as fatigue and nausea, which occur frequent...
(Date:11/6/2009)...N, Pa., Nov. 6 In consultation wit...eil Consumer Healthcare, Division of McNEIL-PPC, I... number of product lots of TYLENOL® Arthritis...ve red EZ-OPEN CAP. McNeil is initiating the recal...aste associated with these lots that led to a smal...
(Date:11/6/2009)... Kaiser Foundation Health Plan, Inc... subsidiaries reported today a combined total oper...ed September 30, 2009, compared to $10.2 billion i... in the third quarter was $336 million, compared t...Net non-operating income was $233 million in the t...
Breaking Medicine Technology:Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 4ONRAD Announces its 26quot 3BName Our Ant 26quot 3B Competition 51416 1Six Scientists Receive Awards for Contributions to Alzheimers Disease Research 51414 1Six Scientists Receive Awards for Contributions to Alzheimers Disease Research 51414 2Six Scientists Receive Awards for Contributions to Alzheimers Disease Research 51414 3Six Scientists Receive Awards for Contributions to Alzheimers Disease Research 51414 4PTSD Associated With Higher Alzheimers Dementia Risk 3B Moderate Alcohol Consumption May Lower it 4715 1PTSD Associated With Higher Alzheimers Dementia Risk 3B Moderate Alcohol Consumption May Lower it 4715 2PTSD Associated With Higher Alzheimers Dementia Risk 3B Moderate Alcohol Consumption May Lower it 4715 3PTSD Associated With Higher Alzheimers Dementia Risk 3B Moderate Alcohol Consumption May Lower it 4715 4PTSD Associated With Higher Alzheimers Dementia Risk 3B Moderate Alcohol Consumption May Lower it 4715 5PTSD Associated With Higher Alzheimers Dementia Risk 3B Moderate Alcohol Consumption May Lower it 4715 6
...lence of dementia may be much higher than previous...veloped regions - , , LONDON and SINGAPORE, Marc... of Alzheimer,s Disease International (ADI) addres...of Alzheimer,s and dementia, as well as new ways b...g brain disorder. , , Scientists at the conferen...
...for company,s first-in-class SERM designed to reli...ated with hormone therapy-- , , CAMBRIDGE, Mass.,...y that the first patient has been dosed in the com... an investigational selective estrogen receptor mo...treatment of vasomotor symptoms (menopausal hot fl...
Other Medicine Technology:Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion 2Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion 3Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion 4Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion 5Worldwide Cost Estimate for Alzheimer's and Dementia Is US$315.4 Billion 6Radius Initiates Phase 2a Clinical Trial of RAD1901 in Menopausal Hot Flashes 2Radius Initiates Phase 2a Clinical Trial of RAD1901 in Menopausal Hot Flashes 3
(Date:11/8/2009)...for Swift Passage of H.R. 3961 to Secure the Stabi...e-USNewswire/ -- Statement Attributable to: J. Jam...iation. ,, (Logo: http://www.newscom.com/cgi-... the passage of the House health reform bill, whic... and physicians and calls for swift passage of H.R...
(Date:11/8/2009)...raises House Passage of Health Care Reform Bill ,...re, improve coverage for all Americans ,, BALT... Tonight the United States House of Representativ...that would strengthen Medicare for seniors and end... millions of Americans out of affordable health co...
(Date:11/7/2009)..., Nov. 7, The American ...enjamin Rush Award for Citizenship and Community S... from Chicago, IL. The award recognizes physicians... call of duty to make an outstanding public servic... received the award today during the opening sessi...
(Date:11/7/2009)..., Nov. 7 Members of the...an emergency resolution rescinding the AMA,s suppo...s that they are responsible to their PATIENTS, not...Director of Policy for the Association of American...a coalition of other medical groups. ,, "If th...
(Date:11/7/2009)...TON, Nov. 7 Speaker Nan...lability this afternoon following a Democratic Whi...s Room. Below are the Speaker,s opening remarks: ...s a great occasion for us to receive the President...making history with our vote and making progress f...
Breaking Medicine News(10 mins):Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2
...he Providence Service,Corporation (Nasdaq: PRSC ...y,s,Chief Operating Officer, has been appointed to...pointment fills the vacancy left by the April 2008... age 41, has been with Providence since its incept...
...iversity of Texas M. D. Anderson Cancer Center ma...adicate breast cancer in Panama through the Partne...the Americas today at an event with Laura Bush, th...he U.S. Department of State and Susan G. Komen for...
...neral membership of the Medical,Advertising Hall o...eir Annual,Awards Dinner to be held February 10, 2...hievement Award will also be given. , The 20...amp; Hennessey. In 1980 he left Sudler & Henne...
... deadly diseaseits cause remains a mysteryswept in... with citizens, soldiers and refugees of the war t...illed with corpses, social order broke down. Over ...ning of the end of the Golden Age of Greece. , T...
...pe Research(TM), a revolutionary,biometric media r...asurement,announced today the appointment of three...arch and development, business strategy and market...ce President of,Strategy; Dr. Ravi Kothuri as Vice...
...Gilbert Hospital, known for setting new trends in ...r service campaign entitled S.M.I.L.E. The acronym...rship; Excellence was developed by Gilbert Hospita...ame to life in order to provide enhanced services ...
Other Medicine News:Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2Health News:Gilbert Hospital Kicks Off New Customer Service S.M.I.L.E. Campaign 2
CTK Corneal Topographer / Keratograph
...es the old technology, the automated projector. St...virtually unlimited charts to the patient in a ran... finger tips. The STIMULi supports many types of ...and fixation devices in a simple remote controlled...
Two-mirror Contact Lens 905 S
One-mirror Contact Lens 904
Medicine Products: